Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2102274233', 'doi': 'https://doi.org/10.1517/14740338.4.1.45', 'title': 'Toxicity of the topoisomerase I inhibitors', 'display_name': 'Toxicity of the topoisomerase I inhibitors', 'publication_year': 2005, 'publication_date': '2005-01-01', 'ids': {'openalex': 'https://openalex.org/W2102274233', 'doi': 'https://doi.org/10.1517/14740338.4.1.45', 'mag': '2102274233', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15794715'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/14740338.4.1.45', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S20709540', 'display_name': 'Expert Opinion on Drug Safety', 'issn_l': '1474-0338', 'issn': ['1474-0338', '1744-764X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5084409602', 'display_name': 'Karen Seiter', 'orcid': 'https://orcid.org/0000-0003-3838-7901'}, 'institutions': [{'id': 'https://openalex.org/I181190671', 'display_name': 'New York Medical College', 'ror': 'https://ror.org/03dkvy735', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I181190671']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Karen Seiter', 'raw_affiliation_strings': ['New York Medical College, Room 250 Munger Pavilion, Valhalla, New York 10595, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'New York Medical College, Room 250 Munger Pavilion, Valhalla, New York 10595, USA. [email protected]', 'institution_ids': ['https://openalex.org/I181190671']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5084409602'], 'corresponding_institution_ids': ['https://openalex.org/I181190671'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.3, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 96, 'citation_normalized_percentile': {'value': 0.684676, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '4', 'issue': '1', 'first_page': '45', 'last_page': '53'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'DNA Topoisomerases: Structure, Function, and Inhibition', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'DNA Topoisomerases: Structure, Function, and Inhibition', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12172', 'display_name': 'Management of Febrile Neutropenia in Cancer Patients', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/mitoxantrone', 'display_name': 'Mitoxantrone', 'score': 0.72471315}, {'id': 'https://openalex.org/keywords/neurotoxicity', 'display_name': 'Neurotoxicity', 'score': 0.472853}, {'id': 'https://openalex.org/keywords/broad-spectrum', 'display_name': 'Broad spectrum', 'score': 0.47125104}, {'id': 'https://openalex.org/keywords/topoisomerase-inhibitor', 'display_name': 'Topoisomerase inhibitor', 'score': 0.44804016}, {'id': 'https://openalex.org/keywords/cardiac-toxicity', 'display_name': 'Cardiac toxicity', 'score': 0.4477765}, {'id': 'https://openalex.org/keywords/cardiotoxicity', 'display_name': 'Cardiotoxicity', 'score': 0.42023104}], 'concepts': [{'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.85275733}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.8501857}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8389126}, {'id': 'https://openalex.org/C2780923524', 'wikidata': 'https://www.wikidata.org/wiki/Q239426', 'display_name': 'Mitoxantrone', 'level': 3, 'score': 0.72471315}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6162385}, {'id': 'https://openalex.org/C3020442560', 'wikidata': 'https://www.wikidata.org/wiki/Q4971815', 'display_name': 'Broad spectrum', 'level': 2, 'score': 0.47125104}, {'id': 'https://openalex.org/C2778616834', 'wikidata': 'https://www.wikidata.org/wiki/Q281044', 'display_name': 'Topoisomerase inhibitor', 'level': 4, 'score': 0.44804016}, {'id': 'https://openalex.org/C2910163948', 'wikidata': 'https://www.wikidata.org/wiki/Q2118956', 'display_name': 'Cardiac toxicity', 'level': 3, 'score': 0.4477765}, {'id': 'https://openalex.org/C2778233292', 'wikidata': 'https://www.wikidata.org/wiki/Q2118956', 'display_name': 'Cardiotoxicity', 'level': 3, 'score': 0.42023104}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26309064}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.20049974}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.15269694}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.086646706}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.07119593}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C21951064', 'wikidata': 'https://www.wikidata.org/wiki/Q899212', 'display_name': 'Combinatorial chemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D059005', 'descriptor_name': 'Topoisomerase II Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003630', 'descriptor_name': 'Daunorubicin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D003630', 'descriptor_name': 'Daunorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015251', 'descriptor_name': 'Epirubicin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D015251', 'descriptor_name': 'Epirubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015255', 'descriptor_name': 'Idarubicin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D015255', 'descriptor_name': 'Idarubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007938', 'descriptor_name': 'Leukemia', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D007938', 'descriptor_name': 'Leukemia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008942', 'descriptor_name': 'Mitoxantrone', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008942', 'descriptor_name': 'Mitoxantrone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D052016', 'descriptor_name': 'Mucositis', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D052016', 'descriptor_name': 'Mucositis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011034', 'descriptor_name': 'Podophyllotoxin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011034', 'descriptor_name': 'Podophyllotoxin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013713', 'descriptor_name': 'Teniposide', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013713', 'descriptor_name': 'Teniposide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014652', 'descriptor_name': 'Vascular Diseases', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D014652', 'descriptor_name': 'Vascular Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/14740338.4.1.45', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S20709540', 'display_name': 'Expert Opinion on Drug Safety', 'issn_l': '1474-0338', 'issn': ['1474-0338', '1744-764X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15794715', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.82, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 154, 'referenced_works': ['https://openalex.org/W107098111', 'https://openalex.org/W1432929478', 'https://openalex.org/W146134068', 'https://openalex.org/W1480716635', 'https://openalex.org/W1492360552', 'https://openalex.org/W1536538430', 'https://openalex.org/W1542075887', 'https://openalex.org/W1585209741', 'https://openalex.org/W1586763410', 'https://openalex.org/W1597090878', 'https://openalex.org/W1676354228', 'https://openalex.org/W1791262955', 'https://openalex.org/W1796787464', 'https://openalex.org/W1814791463', 'https://openalex.org/W1816122400', 'https://openalex.org/W1828224642', 'https://openalex.org/W1831044128', 'https://openalex.org/W1832060645', 'https://openalex.org/W1835830368', 'https://openalex.org/W1854708637', 'https://openalex.org/W1855714470', 'https://openalex.org/W1861929829', 'https://openalex.org/W1869323251', 'https://openalex.org/W1876135160', 'https://openalex.org/W1882532563', 'https://openalex.org/W1893347245', 'https://openalex.org/W1897082568', 'https://openalex.org/W1897951801', 'https://openalex.org/W1903533038', 'https://openalex.org/W1911376378', 'https://openalex.org/W1913802169', 'https://openalex.org/W1919288105', 'https://openalex.org/W1932169383', 'https://openalex.org/W1932625604', 'https://openalex.org/W1941332786', 'https://openalex.org/W1945936026', 'https://openalex.org/W1949633840', 'https://openalex.org/W1956382989', 'https://openalex.org/W1963335440', 'https://openalex.org/W1964060298', 'https://openalex.org/W1965850318', 'https://openalex.org/W1971100415', 'https://openalex.org/W1971131344', 'https://openalex.org/W1975204412', 'https://openalex.org/W1975298683', 'https://openalex.org/W1975989740', 'https://openalex.org/W1977105311', 'https://openalex.org/W1979869104', 'https://openalex.org/W1979904309', 'https://openalex.org/W1981863738', 'https://openalex.org/W1981987977', 'https://openalex.org/W1982230933', 'https://openalex.org/W1984619574', 'https://openalex.org/W1985259498', 'https://openalex.org/W1987992642', 'https://openalex.org/W1990344014', 'https://openalex.org/W1991058838', 'https://openalex.org/W1992292837', 'https://openalex.org/W2006824814', 'https://openalex.org/W2006864755', 'https://openalex.org/W2010344663', 'https://openalex.org/W2011941911', 'https://openalex.org/W2014698797', 'https://openalex.org/W2016127498', 'https://openalex.org/W2018185888', 'https://openalex.org/W2022361916', 'https://openalex.org/W2028636882', 'https://openalex.org/W2032687836', 'https://openalex.org/W2035287003', 'https://openalex.org/W2036296711', 'https://openalex.org/W2041330854', 'https://openalex.org/W2041996138', 'https://openalex.org/W2044063690', 'https://openalex.org/W2046789782', 'https://openalex.org/W2047991220', 'https://openalex.org/W2051002936', 'https://openalex.org/W2051557244', 'https://openalex.org/W2053340754', 'https://openalex.org/W2070010470', 'https://openalex.org/W2070825008', 'https://openalex.org/W207118996', 'https://openalex.org/W2072665226', 'https://openalex.org/W2073636635', 'https://openalex.org/W2073678209', 'https://openalex.org/W2074965477', 'https://openalex.org/W2077562461', 'https://openalex.org/W2077621121', 'https://openalex.org/W2079139674', 'https://openalex.org/W2082497491', 'https://openalex.org/W2087824134', 'https://openalex.org/W2089978656', 'https://openalex.org/W2090686528', 'https://openalex.org/W2092975253', 'https://openalex.org/W2095822339', 'https://openalex.org/W2096048221', 'https://openalex.org/W2096122707', 'https://openalex.org/W2096593771', 'https://openalex.org/W2097257602', 'https://openalex.org/W2101760255', 'https://openalex.org/W2104628239', 'https://openalex.org/W2104877080', 'https://openalex.org/W2106016270', 'https://openalex.org/W2108018389', 'https://openalex.org/W2111426313', 'https://openalex.org/W2115313171', 'https://openalex.org/W2119172537', 'https://openalex.org/W2119539583', 'https://openalex.org/W2122240105', 'https://openalex.org/W2125942822', 'https://openalex.org/W2126964833', 'https://openalex.org/W2128403792', 'https://openalex.org/W2128447158', 'https://openalex.org/W2130168443', 'https://openalex.org/W2131135213', 'https://openalex.org/W2132122697', 'https://openalex.org/W2134844954', 'https://openalex.org/W2135296895', 'https://openalex.org/W2138344872', 'https://openalex.org/W2138602439', 'https://openalex.org/W2148550474', 'https://openalex.org/W2151516332', 'https://openalex.org/W2153050324', 'https://openalex.org/W2154402133', 'https://openalex.org/W2159256284', 'https://openalex.org/W2160684474', 'https://openalex.org/W2163106700', 'https://openalex.org/W2169857347', 'https://openalex.org/W2171228726', 'https://openalex.org/W2172665548', 'https://openalex.org/W2172761866', 'https://openalex.org/W2190800131', 'https://openalex.org/W2191003384', 'https://openalex.org/W2202035925', 'https://openalex.org/W2215662325', 'https://openalex.org/W2232368099', 'https://openalex.org/W2260360964', 'https://openalex.org/W2261113403', 'https://openalex.org/W2267306625', 'https://openalex.org/W2285731702', 'https://openalex.org/W2295658630', 'https://openalex.org/W2313924227', 'https://openalex.org/W2314927739', 'https://openalex.org/W2317936438', 'https://openalex.org/W2318605753', 'https://openalex.org/W2318674152', 'https://openalex.org/W2337432642', 'https://openalex.org/W2398774730', 'https://openalex.org/W2416681109', 'https://openalex.org/W2419673119', 'https://openalex.org/W305459207', 'https://openalex.org/W4234183534', 'https://openalex.org/W4237181574', 'https://openalex.org/W4256155241', 'https://openalex.org/W91972951'], 'related_works': ['https://openalex.org/W60351979', 'https://openalex.org/W4387616930', 'https://openalex.org/W4376630084', 'https://openalex.org/W2562144170', 'https://openalex.org/W2478496593', 'https://openalex.org/W2152846671', 'https://openalex.org/W2090073585', 'https://openalex.org/W2015250033', 'https://openalex.org/W1984515525', 'https://openalex.org/W1929164375'], 'abstract_inverted_index': {'Topoisomerase': [0, 18], 'II': [1, 19], 'inhibitors': [2, 20], 'represent': [3], 'a': [4, 11], 'broad': [5], 'class': [6], 'of': [7, 14, 39, 54], 'antineoplastic': [8], 'agents': [9, 56], 'with': [10, 59], 'wide': [12], 'spectrum': [13], 'activity': [15], 'against': [16], 'malignancies.': [17], 'include': [21], 'the': [22, 65], 'anthracyclines,': [23], 'mitoxantrone': [24], 'and': [25, 31, 42, 64], 'epipodophyllotoxins.': [26], 'Short-term': [27], 'toxicity': [28, 41], 'includes': [29], 'myelosuppression': [30], 'gastrointestinal': [32], 'toxicity.': [33], 'Long-term': [34], 'survivors': [35], 'are': [36], 'at': [37], 'risk': [38], 'cardiac': [40], 'secondary': [43], 'leukaemia.': [44], 'This': [45], 'article': [46], 'discusses': [47], 'these': [48, 55], 'toxicities': [49], 'in': [50, 70], 'detail,': [51], 'including': [52], 'administration': [53], 'to': [57], 'patients': [58], 'hepatic': [60], 'and/or': [61], 'renal': [62], 'insufficiency,': [63], 'need': [66], 'for': [67], 'dose': [68], 'adjustments': [69], 'selected': [71], 'patient': [72], 'populations.': [73]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2102274233', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 8}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 8}, {'year': 2018, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 5}, {'year': 2015, 'cited_by_count': 3}, {'year': 2014, 'cited_by_count': 6}, {'year': 2013, 'cited_by_count': 11}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-09-09T23:25:26.458978', 'created_date': '2016-06-24'}